brands

Thomson CompuMark, (Boston, MA), a Thomson Reuters business, announced new, proprietary FDA drug sources in its Pharmaceutical XC Search, plus authentic FDA Phonetic Orthographic Computer Analyses (POCAs) of potential marks, both of which reduce the risk of pharmaceutical brand conflicts.